NI-0801
Based on 1 Customer Validation
NI-0801 (EB 06) is a CXCL10 inhibitor with a Kd of 140 pM. NI-0801 blocks the CXCL10-CXCR3 interaction. NI-0801 selectively binds human CXCL10 but not CXCL9 or CXCL11, and inhibits CXCL10-induced calcium flux, chemotaxis, and lymphocyte transendothelial migration.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.19%
- 분자량:146.08 kDa
-
보관:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[3]|
CXCL10 140 pM (Kd) |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
신청
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Human IP-10/CXCL10 Protein can bind NI-0801. The EC50 for this effect is 2.326 ng/mL.
Chemical Information
-
Appearance Liquid
-
분자량 146.08 kDa
-
Color Colorless to light yellow
-
Synonyms
EB 06
-
선적
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (259 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)